Health Care Innovations

Technology continues to transform the health care sector, driving innovations in delivery and treatments while improving quality and increasing efficiency. The COVID-19 public health emergency has focused the public on the need for innovative health care solutions to diversify the range of diagnostic and treatment options for patients. To maximize their market potential, however, innovators require cutting-edge legal and policy solutions.

Our integrated team combines the firm’s lauded public policy, regulatory and legal experience to guide clients through the complex regulatory and policy matters that are part of building and commercializing transformative developments in health care—assisting from an idea’s inception to its successful commercialization.

We provide targeted, strategic advice to clients ranging from large companies with broad product portfolios to start-ups bringing their first products to market. Our health care innovations lawyers and advisors work closely with our investment funds group to advise venture capital and private equity firms in unlocking market potential for emerging technologies.

With former members of Congress, congressional committee staff and senior federal agency officials within our ranks, we have first-hand knowledge of the intricacies of product development and approval, coverage and reimbursement and related public policy issues.

Our team has decades of collective government experience—a number of our practitioners have served in prominent roles within the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS).

Along with our intellectual property, corporate governance, transactions, corporate compliance, and privacy, cybersecurity and data protection teams, our skills combine to help organizations bring their health care innovations to market and lay the foundation for long-term success.